Hostname: page-component-74656f9884-j7cmm Total loading time: 0 Render date: 2026-11-09T01:39:39.821Z Has data issue: false hasContentIssue false

Bench evaluation of MyVal OCTACOR THVs at expansion limits for paediatric and valve-in-valve applications

Published online by Cambridge University Press:  10 October 2025

Raymond N. Haddad*
Affiliation:
Filière des Cardiopathies Congénitales Enfant Adultes, Hôpital Marie Lannelongue, Centre Constitutif du Réseau Maladies Rares Malformations Cardiaques Congénitales Complexes - M3C, Hôpitaux Saint Joseph et Marie Lannelongue, Le Plessis Robinson, France Faculté de Médecine Kremlin-Bicêtre, Université Paris-Saclay, Orsay, France Université Paris-Saclay, INSERM, UMR_S 999, Hypertension Pulmonaire : Physiopathologie and Innovation Thérapeutique (HPPIT), AP-HP, Hôpital Bicêtre, Hôpital Marie Lannelongue (Groupe Hospitalier Paris Saint Joseph), ERN-LUNG, Le Plessis-Robinson, France Direction de la Recherche et de l’Innovation Médicale (DRIM), Marie Lannelongue Innovation Center (MALIC), Hôpitaux Saint Joseph et Marie Lannelongue, Le Plessis Robinson, France
Vlad Ciobotaru
Affiliation:
Cardiologie, Clinique Les Franciscaines, 3DHeartModeling, Nîmes, France
Sébastien Hascoët
Affiliation:
Filière des Cardiopathies Congénitales Enfant Adultes, Hôpital Marie Lannelongue, Centre Constitutif du Réseau Maladies Rares Malformations Cardiaques Congénitales Complexes - M3C, Hôpitaux Saint Joseph et Marie Lannelongue, Le Plessis Robinson, France Faculté de Médecine Kremlin-Bicêtre, Université Paris-Saclay, Orsay, France Université Paris-Saclay, INSERM, UMR_S 999, Hypertension Pulmonaire : Physiopathologie and Innovation Thérapeutique (HPPIT), AP-HP, Hôpital Bicêtre, Hôpital Marie Lannelongue (Groupe Hospitalier Paris Saint Joseph), ERN-LUNG, Le Plessis-Robinson, France Direction de la Recherche et de l’Innovation Médicale (DRIM), Marie Lannelongue Innovation Center (MALIC), Hôpitaux Saint Joseph et Marie Lannelongue, Le Plessis Robinson, France
Alain Fraisse
Affiliation:
Royal Brompton & Harefield Hospitals, Guy’s & St. Thomas’ NHS Trust and National Heart and Lung Institute, Imperial College, London, UK
*
Corresponding author: Raymond N. Haddad; Email: raymondhaddad@live.com
Rights & Permissions [Opens in a new window]

Abstract

Balloon-expandable MyVal OCTACOR valves were evaluated in 3D-printed conduits under simulated flow. The 20 mm valve functioned from 16–24 mm, rupturing at 27 mm. The 29 mm expanded to 33 mm with mild insufficiency. Findings suggest OCTACOR valves may support repeated valve-in-valve procedures, with the 20 mm showing greater versatility for small-infant mitral replacements and as a potential alternative to Melody valves.

Information

Type
Brief Report
Copyright
© The Author(s), 2025. Published by Cambridge University Press
Figure 0

Figure 1. 20 mm MyVal OCTACOR valve under-expanded at 16 mm, then dilated at 18, 22, 24, and 27 mm.

Figure 1

Figure 2. 29 mm MyVal OCTACOR valve under-expanded at 23 mm, then dilated at 25, 27, 32, and 33 mm.

Supplementary material: File

Haddad et al. supplementary material 1

Haddad et al. supplementary material
Download Haddad et al. supplementary material 1(File)
File 10.9 KB
Supplementary material: File

Haddad et al. supplementary material 2

Haddad et al. supplementary material
Download Haddad et al. supplementary material 2(File)
File 11.3 MB
Supplementary material: File

Haddad et al. supplementary material 3

Haddad et al. supplementary material
Download Haddad et al. supplementary material 3(File)
File 10.4 MB
Supplementary material: File

Haddad et al. supplementary material 4

Haddad et al. supplementary material
Download Haddad et al. supplementary material 4(File)
File 16.1 MB